No. 14 – Maccabi Tel Aviv | |
---|---|
Position | Center / Power forward |
League | Israeli Basketball Premier League EuroLeague |
Personal information | |
Born | Havana, Cuba | October 31, 1993
Nationality | Cuban |
Listed height | 6 ft 9 in (2.06 m) |
Listed weight | 242 lb (110 kg) |
Career information | |
NBA draft | 2015: undrafted |
Playing career | 2015–present |
Career history | |
2014–2015 | Capitalinos |
2015–2018 | Estudiantes Concordia |
2018–2019 | Boca Juniors |
2019–2021 | San Pablo Burgos |
2021–2023 | Valencia |
2023–present | Maccabi Tel Aviv |
Career highlights and awards | |
| |
Jasiel "Papi" Rivero Fernández (born October 31, 1993) is a Cuban professional basketball player for Maccabi Tel Aviv of the Israeli Basketball Premier League and the EuroLeague.
Professional career
Argentina (2015–2019)
Rivero made his professional debut on January 1, 2016, for Estudiantes Concordia. Rivero played with Boca Juniors for the 2018–19 season, averaging 18.1 points per game (2nd in the league).[1]
San Pablo Burgos (2019–2021)
On September 9, 2019, Rivero signed with San Pablo Burgos of the Liga ACB. Rivero would play a key part in San Pablo Burgos success in the Basketball Champions League as the club became champions both in the 2019-20 and 2020–21 campaigns.
Valencia Basket (2021–2023)
On July 15, 2021, despite interest from clubs such as Panathinaikos,[2] Rivero decided to sign with Valencia Basket of the Liga ACB.[3] He reunited himself with his former head coach Joan Peñarroya.
Maccabi Tel Aviv (2023–present)
On July 30, 2023, Rivero signed with Israel powerhouse Maccabi Tel Aviv.
National team career
Rivero represented Cuba during the 2015 FIBA Americas Championship. He averaged 18.8 points, 6.5 rebounds, and 0.5 assists.
References
- ↑ "Argentinian Liga A Stats - RealGM". basketball.realgm.com.
- ↑ "Panathinaikos showing strong interest in Jasiel Rivero". eurohoops.net. July 7, 2021. Retrieved November 26, 2021.
- ↑ "Jasiel Rivero leaves Burgos, signs with Valencia". eurohoops.net. July 15, 2021. Retrieved November 26, 2021.